Article
Why do results conflict regarding the prognostic value of the methylation status in colon cancers? The role of the preservation method.
BMC cancer - 13 Jan 2012
Tournier Benjamin, Chapusot Caroline, Courcet Emilie, Martin Laurent, Lepage Côme, Faivre Jean, Piard Françoise
Abstract excerpt
BACKGROUND: In colorectal carcinoma, extensive gene promoter hypermethylation is called the CpG island methylator phenotype (CIMP). Explaining why studies on CIMP and survival yield conflicting results is essential. Most experiments to measure DNA methylation rely on the sodium bisulfite conversion of unmethylated cytosines into uracils. No study has evaluated the performance of bisulfite conversion and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
